Viewing Study NCT00162227


Ignite Creation Date: 2025-12-25 @ 5:18 AM
Ignite Modification Date: 2025-12-26 @ 4:26 AM
Study NCT ID: NCT00162227
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2014-01-09
First Post: 2005-09-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module